乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: 乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS
產(chǎn)品型號(hào): MEpiCGS
產(chǎn)品展商: ScienCell
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS 乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS 上海 安徽 合肥 ScienCell細(xì)胞庫(kù)?
乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS
的詳細(xì)介紹
Mammary Epithelial Cell Growth Supplement (MEpiCGS) is a medium supplement designed for the optimal growth of human normal mammary epithelial cells in vitro. It is a sterile, concentrated (100X) solution which contains growth factors, hormones, and proteins necessary for the culture of normal human epithelial cells. The supplement is formulated (quantitatively and qualitatively) to provide a defined and optimally balanced growth environment that maximally promotes the growth of human normal mammary epithelial cells in vitro. The supplement is designed as an additive for mammary epithelial cell medium (MEpiCM, Cat. No. 7611) and should be used in conjunction with that medium.
|
貨號(hào)
|
7652
|
|
產(chǎn)地
|
美國(guó)
|
|
縮寫
|
MEpiCGS
|
|
規(guī)格
|
5ml
|
|
用途
|
科研
|
|
儲(chǔ)存
|
-20度
|
|
運(yùn)輸
|
膠冰
|
|
關(guān)鍵字
|
乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS；乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS；乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS；乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS；乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS；乳腺上皮細(xì)胞生長(zhǎng)添加物 MEpiCGS
|
公司簡(jiǎn)介
|
合肥星肽生物科技有限公司作為專業(yè)的ScienCell中國(guó)代理商，專業(yè)經(jīng)營(yíng)實(shí)驗(yàn)室科研用原代細(xì)胞、原代細(xì)胞專用培養(yǎng)基、原代細(xì)胞無(wú)血清培養(yǎng)基、干細(xì)胞、干細(xì)胞培養(yǎng)基、干細(xì)胞無(wú)血清培養(yǎng)基的研究和開(kāi)發(fā)。合肥星肽生物科技有限公司始終致力于為客戶提供可靠的研究材料以及方便快捷的服務(wù)，對(duì)購(gòu)買項(xiàng)目的前期資料提供,中期合同保證,后期貨物跟蹤到 *終售后的確保項(xiàng)目準(zhǔn)確到位，都有相關(guān)專業(yè)人士進(jìn)行維護(hù),確保您在合肥合肥星肽生物科技有限公司公司獲得*上等服務(wù)！
|
|
聯(lián)系方式
|
何經(jīng)理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898，
E-mail：info@qingbio.com http://m.27846.cn QQ:514713116
|
1.) Zhang L, Webster TJ. (2013) "Effects of chemically modified nanostructured PLGA on functioning of lung and breast cancer cells." Int J Nanomedicine. 8: 1907-19.
There are no product questions yet.
